Navigation Links
Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
Date:12/11/2007

FREMONT, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Panomics Inc., a developer of innovative technologies and products for Parallel Quantitative Biology (PQB)(TM), and the exclusive provider of QuantiGene(R) and QuantiGene Plex(R) products for gene expression measurement and profiling, announced today that they have been awarded Frost & Sullivan's 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award. Frost & Sullivan, a global consulting firm, presented the award last week during the Awards Banquet in Orlando.

The Frost & Sullivan Entrepreneurial Company of the Year Award is presented each year to the small company that demonstrated superior entrepreneurial ability in its industry during the research period. This Award signifies the company's identification of a unique and revolutionary product solution with significant market potential. Additionally, the Award certifies that the company's marketing strategy is sound and poised for success.

Panomics' products, primarily highly quantitative single and multiplex RNA and protein analysis tools, are aimed at critical applications downstream of whole genome studies. For example, our products are used in gene silencing studies, cell signaling research and biomarker validation. Very recently, Panomics has been selected as the first provider of gene expression analysis technology to be adopted for primary high throughput screening at a top 5 pharma company, a development our customer believes will greatly improve productivity -- and reduce cost -- of drug discovery.

"The complexity of cellular signaling requires a multi-faceted approach in order to characterize all of the events occurring in a cell," states Frost & Sullivan Industry Analyst Shankar Sellappan, Ph.D. "Panomics has taken this strategy to heart and developed the concept of Parallel Quantitative Biology to recognize, measure and characterize these events. In addition, the applications of Panomics tec
'/>"/>

SOURCE Panomics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
4. 2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced
5. PureCart Systems of Green Bay, Wis., is an Honored Recipient of an iParenting Media Award
6. Nobel Honors 3 Former March of Dimes Prize Recipients
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Dr. Yu Yamaguchi named recipient of the Humanitarian Scientific Achievement Award
9. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
10. CHF International Named Global Fund Principal Recipient in Honduras
11. Will Rogers Institute to Honor Worlds Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...icular cancer who were treated with cisplatin-base...ding neurological side effects and Raynaud-like ph...herapy, according to a new study published online ... Institute . , Marianne Brydy, M.D., of the Depa... in Bergen, Norway, and colleagues conducted a cro...
(Date:11/25/2009)...at grew out of a collaboration between UCLA engine... the nearly 10 million Americans who suffer from p...hardening of the arteries, peripheral arterial dis...hich narrowed arteries reduce blood flow to the li...scular disease, heart attack and stroke, and its p...
(Date:11/25/2009)...s too short to draw definite conclusions, experts ...News) -- In diabetic patients with blocked coronar...utcomes at one year whether patients undergo bypas...searchers report. , Bypass surgery has been the...onary artery disease. However, less invasive appro...
(Date:11/25/2009)...luation and treatment clinics to resume Monday, No... November 25, 2009 -- Centegra Health System is co...cine shots at four Centegra Primary Care (CPC) vac... has arrived. The clinics are at CPC sites in Hunt...be open as follows: ,   From 4:30 to 7...
(Date:11/25/2009)...urological symptoms, study finds , , WE...side effects are among the potential problems face...were treated with cisplatin-based chemotherapy, a ... Norwegian men treated for unilateral testicular c...low-up survey conducted from 1998 to 2002. , Th...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...shington – Today, the nursing profession is sought...reign countries has made the noble profession,// l...to foreign lands, in search of greener pastures. T...omeland to find work in the Unites States. In the ...
... a tragic mistake, the young life of John Mealey, ... infection for a simple// hangover. Describin... centre for excellence for this very type of condi...y was admitted to Aintree Hospitals NHS Trust - a ...
...w Haven, Conn. — Recurring chlamydia infections ar...o a Yale Department of Epidemiology and Public Hea...istant professor in the division of Epidemiology o...osed with chlamydia and then, in a rate higher tha...
...tamin A deficiency has resulted in blindness among...of India, a study has found.// As much as 51... blind in that region have become blind over a per...the North East, a study reveals. There is a sing...
...top drug regulator told lawmakers Monday it could ... safely approve generic versions of biotech drugs ...ditional drugs. Food and Drug Administration d... in the U.S. for their products, some of the most ...
...premier Indian medical institution failed to infor...positive. The girl paid for its callousness//, wit...channel. 17-year-old Jyoti, was the daughter of ...Medical Sciences (AIIMS), a prestigious institutio...
Other Medicine News:Health News:‘Drunk’ Doctors Misdiagnosis Proves Fat 2Health News:Recurring Chlamydia Infections Common in Teenage Girls 2Health News:FDA Cites Challenges of Generic Biotech 2Health News:Patient Pays For The Callousness Of Hospital Administration 2
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.com...itscatalogue: ,, UnitedStatesDentalDevicesMark...portlinker.com/p0158733/United-States-Dental-Devic..., UnitedStatesDentalDevicesMarketAnalysisandForec...entialsourceforin-depthinformationanddatarelatingt...
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVas...edondevelopingproductsforminimallydisruptivesurgic...staconferencecallonMonday,November30,2009,at5:30p....tissuesrelativetoreimbursementfortheCompany,sprodu...shortquestionandanswersession.Thedial-innumbersare...
(Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-...WR ;ASX:HIN),aleadinginnovatorandprovideroflessinv...volutionizingthetreatmentofadvancedheartfailure,to...ntationatthe21stAnnualPiperJaffrayHealthCareConfer...renceisbeingheldattheNewYorkPalaceHotel,December1-...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Families With Special Needs Children Need Special Financial Strategies 53581 1Families With Special Needs Children Need Special Financial Strategies 53581 2Families With Special Needs Children Need Special Financial Strategies 53581 3Sustainable agriculture at the ESA Annual Meeting 9466 1Sustainable agriculture at the ESA Annual Meeting 9466 2Sustainable agriculture at the ESA Annual Meeting 9466 3Sustainable agriculture at the ESA Annual Meeting 9466 4FDA selects Sensotech 26apos 3Bs Wireless Temperature Monitoring System 53576 1FDA selects Sensotech 26apos 3Bs Wireless Temperature Monitoring System 53576 2
...Hit Therapeutics,(Alternext: ALEHT) is pleased to ...d compound in Alzheimer,s disease, is progressing ...sessing EHT 0202 in patients with,Alzheimer,s dise... of patient enrolment for the Phase IIa,represents...0202, and,provides a clear timeline for the releas...
...o long for surgery, study finds , , LAS VEGAS, Fe... to have poorer joint function before undergoing h... study presented today at the 2009 Annual Meeting ...(AAOS) ( http://www.aaos.org/ ). In addition, fema...than male patients across ethnic groups. , , "Stu...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4When to Have That Joint Replacement? 2When to Have That Joint Replacement? 3
O-arm Complete Multidimensional Surgical Imaging
ABX Micros IM Hematology Analyzers
Rio™ Aspiration Catheter
Sound Pro Combination Table
Medicine Products: